A Phase II Clinical Trial of TQC3721 Suspension for Inhalation

Stopped Per sponsor request. Closure was not prompted by any safety or efficacy concerns.

Conditions

• Chronic Obstructive Pulmonary Disease (COPD)

Interventions

• DRUG: TQC3721 suspension for inhalation
• DRUG: TQC3721 suspension placebo for inhalation

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.